Add The Good and the Bad of HCG Monotherapy: 5 Important Things Should Know

2026-04-03 09:23:28 +08:00 · 2026-04-03 09:23:28 +08:00 · d0f9af52f3
commit d0f9af52f3
1 changed files with 9 additions and 0 deletions
--- a/The-Good-and-the-Bad-of-HCG-Monotherapy%3A-5-Important-Things-Should-Know.md
+++ b/The-Good-and-the-Bad-of-HCG-Monotherapy%3A-5-Important-Things-Should-Know.md
@ -0,0 +1,9 @@
 <br>
 <br>Testosterone replacement therapy should be offered to all patients with male hypogonadism provided that there are no contraindications (Table 2) and if fertility is not an immediate concern. Testosterone replacement therapy is not appropriate for men who desire seeking fertility because exogenous testosterone will suppress gonadotropins and endogenous testosterone production with consequent decrease in sperm production. Currently, there is no evidence [best place to buy testosterone](http://fanlibo.i234.me:8418/hudsonavila73) indicate that testosterone replacement therapy will induce prostate cancer or cause a histologic prostate cancer to become clinically significant; however [buy testosterone online without prescription](https://git.sskuaixiu.com/fideliaoxq479) treatment may unmask latent/histologic prostate cancer. Hypogonadal men treated with [buy testosterone booster](http://1.95.120.11:3000/britneysigel45) do not have a linear dose response of prostatic specific antigen (PSA) levels, and unless the pre-treatment [buy testosterone propionate](http://39.171.252.63:3000/carolinedunkel) levels are extremely low, do not increase intraprostatic [buy testosterone without prescription](https://indoreindiajobportal.com/employer/facebook) and DHT levels 55,97. Meta-analysis of randomized placebo-controlled clinical trials does not show that testosterone replacement therapy increases the incidence of any prostate disorder including benign prostatic hyperplasia or prostate cancer compared to those treated with placebo . Crops of acne are usually related to higher serum levels of [buy testosterone without prescription](https://www.nastavniki.com/@imamariano5424?page=about) and are less common if relatively stable serum testosterone levels are maintained in the mid-adult male range.
 Men using hCG may experience temporary breast enlargement because hCG increases estradiol levels  . Long-term testosterone replacement does not impair future fertility but may require more time for initiation or re-initiation of spermatogenesis to occur 142,143. The treatment of underlying infiltrative disease may also improve gonadotropin secretion. The treatment of the underlying condition (e.g., nutritional deficiency) or discontinuation of an offending medication (e.g., anabolic steroids, glucocorticoids, opiates) often reverses hypogonadotropic hypogonadism . Patients with hypogonadotropic hypogonadism may require management of the underlying cause (e.g., pituitary tumors) in addition to treating symptoms of hypogonadism. The patient with significantly elevated hematocrit should be carefully monitored and evaluated for symptoms of sleep apnea such as daytime somnolence and morning headaches and for cardiovascular events.
 This regimen provides peak within testosterone levels within the acceptable reference range during the first week after the injection 112,113. There is a greater risk of erythrocytosis with higher maximal peak in testosterone levels with IM injections when compared with transdermal formulations . TP with a short three-carbon ester is not used for testosterone replacement therapy because it lasts only for a few days. Testosterone replacement therapy will increase the growth and proliferation of androgen dependent prostate and male breast cancers.
 The more common causes of primary hypogonadism or hypergonadotropic hypogonadism include chromosomal defects (e.g., Klinefelter syndrome), testicular injury (e.g., chemotherapy, radiation, surgery, trauma) and infection. Primary hypogonadism results from disorders of the testes that lead to low testosterone production and impaired spermatogenesis. The decreased functional ability of the testis to produce adequate amounts of testosterone and/or mature spermatozoa can be due to defects in the testis, pituitary and/or hypothalamus, or at multiple levels. The options of testosterone delivery systems (injections, transdermal patches/gels, buccal tablets, capsules and implants) have increased in the last decade. You can see the same threads on all forums all over again every day - the guy has the symptoms but he is refused treatment because he is in range. And all of them should go on TRT to increase their levels to above 1000 ng/dl to get ‘there’?
 There are also reports that testosterone replacement therapy improves depression 77,78; however the studies are few and controversial. A number of studies have found that testosterone replacement therapy results in decreases in total cholesterol and LDL cholesterol 53,58,62. While the significant weight loss requires careful confirmation, randomized controlled trials showed that testosterone replacement therapy reduced body fat mass, regional fat distribution and waist circumference in hypogonadal men with and without obesity 48,53-61. Testosterone therapy has not been approved by the FDA for treatment of osteoporosis as there are no well-controlled data showing that [buy testosterone cypionate](https://git.lenfortech.com/armandofredric) replacement therapy reduces fracture rate. In pre-pubertal hypogonadal boys, testosterone replacement therapy will initiate puberty and induce development of secondary sexual characteristics. Direct immunoassay for free testosterone does not provide more information than total [testosterone price](https://itimez.com/@karinconcepcio?page=about) and the levels measured are much lower than free testosterone levels estimated by equilibrium dialysis and should not be used for the diagnosis of hypogonadism 24,25.
 In men's hormone care, HCG mimics luteinizing hormone, one of the signaling hormones the brain sends to the testes to stimulate testosterone production and support sperm development. [buy testosterone powder](http://110.41.186.94:3000/lindseyyount81) replacement therapy, commonly called TRT, is used to address low [buy testosterone online no prescription](https://thewordtube.org/@franziskapaspa?page=about) in men. It is a decision that can shape fertility, physical symptoms, mood, and long-term hormonal health in genuinely different ways. Understanding the difference between HCG monotherapy, testosterone-only therapy, and a combined TRT plus HCG approach is not just a matter of clinical trivia. For many men, starting testosterone therapy feels like a clear solution to a frustrating problem. The most important aspect of choosing whether hCG monotherapy is appropriate is first determining if you have primary or secondary hypogonadism. Despite these limitations, the current manuscript provides valuable data in proposing the efficacy and  [207.180.227.11](http://207.180.227.11:3001/deannetrundle2) safety of hCG monotherapy for men not meeting criteria for testosterone therapy.
 Among the entire cohort, HCT levels showed a small but statistically significant decrease, and no VTEs or MACEs were recorded. Although it appears that hCG therapy may decrease HCT, we did not specifically test this in men with secondary erythrocytosis. La Vignera’s findings suggest that hCG may offer a safer form of T therapy, which is consistent with our results. The decrease in PSA demonstrated here further supports hCG’s safety and the increase in T validates its effectiveness.
 <br>